Selling to physicians is one of the hardest audiences in business marketing and one of the easiest to spend money on badly. Doctors are difficult to reach during working hours, sceptical of promotional language by training, bound by institutional purchasing rules they did not write, and frequently not the person who signs the contract even when they are the person who wants the product. Whether you sell devices, software, services or continuing education, the mistake is treating them as a normal business audience with a longer sales cycle. This guide sets out which channels actually reach physicians, what the compliance floor is, and how to judge an agency that claims to know this market.
Who you are actually selling to
The first correction most campaigns need is to the buying unit. A solo practice owner buys like a small business owner and can decide alone. A physician in a group practice usually influences rather than decides, with an administrator or managing partner controlling budget. A hospital-employed physician often cannot buy at all, and the real purchase runs through supply chain, information technology and a value analysis committee that will never see your advertising. Each of these needs different material: the practice owner wants economics and time saved, the group needs a case that survives a partners' meeting, and the health system needs security documentation, integration detail and references from comparable institutions. An agency that proposes one campaign for physicians in general has not asked this question. Ask them at the first meeting which of these segments the plan is aimed at and what the material is for the people around the doctor, because that is where most enterprise health deals are actually won or lost.
Channels that reach physicians, and what each costs you
Search remains the most reliable channel because it catches intent at the moment a clinician is looking for a solution, and it is measurable in a way that most physician-facing media is not. The queries are narrow and expensive, but they convert, and the supporting content has to be written at a level that a specialist will not find insulting. Professional networks and medical associations offer targeted reach at high cost and vary enormously in quality of placement. Medical media, journals and society newsletters carry credibility and are largely unmeasurable, so buy them as awareness with a defined test rather than as performance. Conferences and society meetings remain disproportionately effective for high-value purchases. Email is legitimate where you have consent and a genuine reason to write, and destructive where the list was bought. Peer channels, meaning genuine advocacy from respected clinicians, outperform everything else and cannot be bought outright; where a clinician is compensated in any way, the connection has to be disclosed, and the FTC's endorsement guidance is explicit that this responsibility sits with the advertiser.
The compliance floor
Two constraints shape everything. The first is claims: anything you say about clinical outcomes, safety or comparative effectiveness needs substantiation of the kind a regulator would accept, and marketing teams routinely underestimate how strictly this is read in health contexts. The FTC's health products compliance guidance sets out the standard for health-related advertising claims and it is worth reading before a campaign is briefed rather than after. The second is data. Advertising platforms restrict health-related targeting and personalisation, and Google's healthcare and medicines advertising policy limits what can be promoted and how, which means a campaign designed around audience targeting may simply not be approvable. If your product touches patient information, your marketing stack, forms and analytics fall inside your privacy obligations too, and an agency that wants to install a tag on a patient-facing page without asking about that is a risk to you rather than a partner. Agree in writing who drafts claims, who approves them, and what the takedown process is.
How to vet an agency in this market
Ask which physician segment they have actually sold to and for named clients you can verify. Ask to see material written for clinicians and read it as a clinician would: if it reads like consumer copy with jargon added, they are learning on your budget. Ask how they handle the non-physician decision makers, since a plan with nothing for administrators or committees is half a plan. Ask what their compliance workflow is and who reviews claims before publication. Ask what they would refuse to do. Then agree the measures before the contract starts: qualified demonstrations, verified clinician enquiries and pipeline created are defensible, while impressions, clicks and downloads in a market this small are not. Digital marketing services for physician audiences are usually bought as a monthly retainer, so also agree the review point and the evidence that would justify continuing.
Questions people ask about digital marketing to doctors
Can we target physicians directly on advertising platforms?
Only within limits. Platforms restrict health-related targeting and personalised advertising, and professional networks that allow occupation targeting are expensive. In practice, intent-based search plus content that only a genuine clinician would seek out is the more reliable route than trying to build an audience of doctors.
How long is a realistic sales cycle?
For a practice-level purchase, weeks to a few months. For anything requiring a group vote or a health system review, expect several quarters and a committee you never meet. Budget the marketing programme against that horizon, because judging a physician campaign at ninety days will almost always understate it.
Is content marketing worth it for a clinical audience?
Yes, if it is written at the right level and can be defended. Clinicians read carefully and stop reading at the first thing they know to be wrong. That means expert authorship or review, cited evidence, and honesty about limitations. Volume content strategies work particularly badly here.
What should we refuse from an agency?
Purchased email lists of physicians, unsubstantiated outcome claims, paid clinician endorsements without clear disclosure, and any tracking placed on patient-facing pages without a privacy review. Each one creates a liability that outlives whatever short-term lift it produces, and the exposure lands on you rather than the vendor.